Amgen price target raised by Truist to $380
Truist Securities maintained Amgen at Hold while raising its price target to $380.00 from $362.00, per Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.